PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.72%
Some net income increase while AVGO is negative at -54.55%. John Neff would see a short-term edge over the struggling competitor.
No Data
No Data available this quarter, please select a different quarter.
-168.00%
Negative yoy deferred tax while AVGO stands at 68.14%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
53.66%
SBC growth well above AVGO's 0.18%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-247.40%
Both reduce yoy usage, with AVGO at -113.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-190.30%
Both yoy AR lines negative, with AVGO at -237.54%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-105.13%
Both reduce yoy inventory, with AVGO at -81.57%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
303.45%
AP growth well above AVGO's 179.59%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-505.75%
Negative yoy usage while AVGO is 81.53%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-190.91%
Negative yoy while AVGO is 306.25%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-51.48%
Both yoy CFO lines are negative, with AVGO at -6.33%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
1.23%
Some CapEx rise while AVGO is negative at -12.50%. John Neff would see competitor possibly building capacity while we hold back expansions.
-100.00%
Negative yoy acquisition while AVGO stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
68.79%
Purchases growth of 68.79% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
437.05%
Liquidation growth of 437.05% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
96.79%
We have some outflow growth while AVGO is negative at -212.50%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
143.00%
We have mild expansions while AVGO is negative at -12385.23%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
0.13%
Debt repayment well below AVGO's 7.48%. Michael Burry suspects heavier leverage risk or insufficient cash generation to keep pace.
204.17%
We slightly raise equity while AVGO is negative at -37.29%. John Neff sees competitor possibly preserving share count or buying back shares.
-235.58%
We cut yoy buybacks while AVGO is 71.21%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.